Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio‐marker of fibroproliferative disease?
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The CCN (c yr61, c tgf, n ov) family of modular proteins regulate diverse biological affects including cell adhesion, matrix production, tissue remodelling, proliferation and differentiation. Recent targeted gene disruption studies have demonstrated the CCN family to be developmentally essential for chondrogenesis, osteogenesis and angiogenesis. CCN2 is induced by agents such as angiotensin II, endothelin‐1, glucocorticoids, HGF, TGFβ, and VEGF, and by hypoxia and biomechanical and shear stress. Dysregulated expression of CCN2 has also been widely documented in many fibroproliferative diseases. This mini‐review will focus on CCN2, and the recent progress in understanding CCN2 gene regulation in health and disease. That CCN2 should be considered a novel and informative surrogate clinical bio‐marker for fibroproliferative disease is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradham, D. M., Igarashi, A., Potter, R. L., & Grotendorst, G. R. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.6.1285 · Cited by 880 · cited 2×
“CCN2 was initially identified as a protein secreted by cultured human endothelial cells ( Bradham et al. 1991 ).”
BackgroundConnective tissue growth factor: a mediator of TGF-β action on fibroblasts
Grotendorst, G. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00010-5 · Cited by 761 · cited 2×
“…Canada e-mail: Andrew.leask@schulich.uwo.ca X. Shi-wen :D. J. Abraham Centre for Rheumatology, Royal Free and University College Medical School, University College London (Royal Free Campus), Rowland Hill Street, London NW3 2PF, UK TGFβ in mesenchymal cells (Grotendorst 1997; Leask et al. 2004).”
BackgroundIgarashi, A., Okochi, H., Bradham, D. M., & Grotendorst, G. R. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.6.637 · Cited by 706 · cited 1×
“Although CCN2 is not normally expressed by other mesenchymal cells, it is rapidly induced during the tissue repair process, for example upon injury (Igarashi et al. 1993; Kapoor et al. 2008).”
BackgroundAll in the CCN family: essential matricellular signaling modulators emerge from the bunker
Leask, A., & Abraham, D. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03270 · Cited by 655
Self-citationGrotendorst, G. R., Okochi, H., & Hayashi, N. (1996) · PubMed · Cited by 573
Expression of connective tissue growth factor in human renal fibrosis
Ito, Y., Aten, J., Bende, R. J., Oemar, B. S., Rabelink, T. J., Weening, J. J., & Goldschmeding, R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00820.x · Cited by 562
CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling
Holmes, A., Abraham, D. J., Sa, S., Shiwen, X., Black, C. M., & Leask, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010149200 · Cited by 423 · cited 8×
“The BCE-1 site was originally thought to be involved with the TGFβ-induction of CCN2, but has subsequently been shown to be involved with basal promoter activity (Grotendorst et al. 1996; Leask et al. 2001; Holmes et al. 2001) and in response of the CCN2 promoter to ET-1, through ras/MEK/ERK signal transduction cascad…”
BackgroundInfluentialSelf-citationGene regulation of connective tissue growth factor: new targets for antifibrotic therapy?
Blom, I. E., Goldschmeding, R., & Leask, A. (2002) · Matrix Biology · doi:10.1016/s0945-053x(02)00055-0 · Cited by 338 · cited 2×
“CCN2 is over-expressed in connective tissue pathologies such as in excessive scarring and fibrosis and in stroma surrounding tumors (Blom et al. 2002).”
BackgroundSelf-citationExpression of connective tissue growth factor in experimental rat and human liver fibrosis
Paradis, V., Dargere, D., Vidaud, M., de Gouville, A.-C., Huet, S., Martinez, V., Gauthier, J.-M., Ba, N., Sobesky, R., Ratziu, V., et al. (1999) · Hepatology · doi:10.1002/hep.510300425 · Cited by 324 · cited 2×
“In adult mammals, CCN2 exhibits a restricted expression, produced only by hepatic stellate cells (Paradis et al. 1999; Chen et al. 2001) and kidney mesangial cells (Ito et al.”
BackgroundLuo, Q., Kang, Q., Si, W., Jiang, W., Park, J. K., Peng, Y., Li, X., Luu, H. H., Luo, J., Montag, A. G., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407810200 · Cited by 319 · cited 1×
“Finally, Wnt3a induces CCN2 through a β-catenin-dependent mechanism, although the promoter sequences mediating this action are unknown, they reside within in the first 805 base pairs of the CCN2 proximal promoter (Luo et al. 2004; Chen et al. 2007).”
Background
Cited by
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Jun, J.-I., & Lau, L. F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3599 · Cited by 568
Cutaneous wound healing: recruiting developmental pathways for regeneration
Bielefeld, K. A., Amini-Nik, S., & Alman, B. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1152-9 · Cited by 483
Matricellular Proteins in Cardiac Adaptation and Disease
Frangogiannis, N. G. (2012) · Physiological Reviews · doi:10.1152/physrev.00008.2011 · Cited by 445
Hinz, B. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.009 · Cited by 424
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease
Wang, Q., Usinger, W., Nichols, B., Gray, J., Xu, L., Seeley, T. W., Brenner, M., Guo, G., Zhang, W., Oliver, N., et al. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-4 · Cited by 278
Metadata
- Authors
- Leask, A., Parapuram, S. K., Shi‐wen, X., & Abraham, D. J.
- Venue
- Journal of Cell Communication and Signaling
- Publisher
- Wiley
- Published
- 2009-01-21
- Volume
- 3
- Issue
- 2
- Pages
- 89-94
- ISSN
- 1873-9601 (ISSN-L)
- 1873-961X
- OpenAlex
- W2135861680
- Cited by
- 176
- References
- 53
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio‐marker of fibroproliferative disease? https://app.cochat.ai/papers/10.1007/s12079-009-0037-7
- The paper
- Leask, A., Parapuram, S. K., Shi‐wen, X., & Abraham, D. J. (2009). Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio‐marker of fibroproliferative disease? Journal of Cell Communication and Signaling. https://doi.org/10.1007/s12079-009-0037-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.